Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Mifepristone (Primary)
- Indications Bipolar disorders
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2012 Primary endpoint 'Cambridge-Neuropsychological-Test-Automated-Battery' has not been met.
- 24 Sep 2008 Planned end date changed from Sep 2009 to Dec 2010 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History